P/E Ratio (TTM)
115.48
BeOne Medicines Ltd. currently has a P/E ratio of 115.48. The P/E ratio is a primary valuation multiple used to determine if a stock is overvalued or undervalued relative to its earnings.
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2014-03-31 | -19.74 |
| 2014-06-30 | -19.77 |
| 2014-09-30 | -5.26 |
| 2014-12-31 | -14.45 |
| 2015-03-31 | -5.31 |
| 2015-06-30 | -9.60 |
| 2015-09-30 | -3.80 |
| 2015-12-31 | -2.03 |
| 2016-03-31 | -6.41 |
| 2016-06-30 | -8.26 |
| 2016-09-30 | -5.60 |
| 2016-12-31 | -5.34 |
| 2017-03-31 | -4.59 |
| 2017-06-30 | -3.90 |
| 2017-09-30 | 2.32 |
| 2017-12-31 | -2.83 |
| 2018-03-31 | -3.16 |
| 2018-06-30 | -2.08 |
| 2018-09-30 | -2.31 |
| 2018-12-31 | -1.30 |
| 2019-03-31 | -2.13 |
| 2019-06-30 | -4.10 |
| 2019-09-30 | -1.10 |
| 2019-12-31 | -0.90 |
| 2020-03-31 | -1.21 |
| 2020-06-30 | -1.31 |
| 2020-09-30 | -1.23 |
| 2020-12-31 | -1.18 |
| 2021-03-31 | 9.45 |
| 2021-06-30 | -1.16 |
| 2021-09-30 | -1.32 |
| 2021-12-31 | -0.91 |
| 2022-03-31 | -1.01 |
| 2022-06-30 | -0.67 |
| 2022-09-30 | -0.56 |
| 2022-12-31 | -1.10 |
| 2023-03-31 | -1.42 |
| 2023-06-30 | -1.03 |
| 2023-09-30 | 2.57 |
| 2023-12-31 | -1.53 |
| 2024-03-31 | -1.83 |
| 2024-06-30 | -3.40 |
| 2024-09-30 | -4.38 |
| 2024-12-31 | -4.19 |
| 2025-03-31 | 720.10 |
| 2025-06-30 | 9.23 |
| 2025-09-30 | 9.51 |
| 2025-12-31 | 205.00 |
Annual P/E
| Year | P/E Ratio |
|---|
* P/E ratios are calculated using trailing twelve-month (TTM) earnings. Extreme values may indicate earnings anomalies or cyclical volatility.